These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

678 related items for PubMed ID: 30430284

  • 1. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis.
    Dammacco F, Lauletta G, Russi S, Leone P, Tucci M, Manno C, Monaco S, Ferrari S, Vacca A, Racanelli V.
    Clin Exp Med; 2019 Feb; 19(1):1-21. PubMed ID: 30430284
    [Abstract] [Full Text] [Related]

  • 2. The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements.
    Dammacco F, Lauletta G, Vacca A.
    Clin Exp Med; 2023 Jun; 23(2):255-272. PubMed ID: 35348938
    [Abstract] [Full Text] [Related]

  • 3. The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review.
    Dammacco F, Racanelli V, Russi S, Sansonno D.
    Clin Exp Med; 2016 Aug; 16(3):233-42. PubMed ID: 26935415
    [Abstract] [Full Text] [Related]

  • 4. Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus-Associated Cryoglobulinemia Treated With Direct-Acting Antivirals.
    Bonacci M, Lens S, Londoño MC, Mariño Z, Cid MC, Ramos-Casals M, Sánchez-Tapias JM, Forns X, Hernández-Rodríguez J.
    Clin Gastroenterol Hepatol; 2017 Apr; 15(4):575-583.e1. PubMed ID: 27725289
    [Abstract] [Full Text] [Related]

  • 5. Evolution of Cryoglobulinemia in Direct-Acting Antiviral-Treated Asian Hepatitis C Patients With Sustained Virological Responses: A 4-Year Prospective Cohort Study.
    Chang ML, Cheng JS, Chuang YH, Pao LH, Wu TS, Chen SC, Chang MY, Chien RN.
    Front Immunol; 2022 Apr; 13():823160. PubMed ID: 35371039
    [Abstract] [Full Text] [Related]

  • 6. Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature.
    Giuggioli D, Manfredi A, Colaci M, Manzini CU, Antonelli A, Ferri C.
    Autoimmun Rev; 2013 Sep; 12(11):1058-63. PubMed ID: 23806565
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Rheumatologic manifestations of Hepatitis C Virus.
    Treppo E, Quartuccio L, Ragab G, DE Vita S.
    Minerva Med; 2021 Apr; 112(2):201-214. PubMed ID: 33263372
    [Abstract] [Full Text] [Related]

  • 9. Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis.
    Rutledge SM, Chung RT, Sise ME.
    Hemodial Int; 2018 Apr; 22 Suppl 1():S81-S96. PubMed ID: 29694729
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia.
    Emery JS, Kuczynski M, La D, Almarzooqi S, Kowgier M, Shah H, Wong D, Janssen HLA, Feld JJ.
    Am J Gastroenterol; 2017 Aug; 112(8):1298-1308. PubMed ID: 28291241
    [Abstract] [Full Text] [Related]

  • 11. Cryoglobulinemic glomerulonephritis: clinical presentation and histological features, diagnostic pitfalls and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy.
    Rossi D, Sciascia S, Fenoglio R, Ferro M, Baldovino S, Kamgaing J, Ventrella F, Kalikatzaros I, Viziello L, Solfietti L, Barreca A, Roccatello D.
    Minerva Med; 2021 Apr; 112(2):162-174. PubMed ID: 33198442
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis C virus-related cryoglobulinemic vasculitis.
    Mazzaro C, Mauro E, Ermacora A, Doretto P, Fumagalli S, Tonizzo M, Toffolutti F, Gattei V.
    Minerva Med; 2021 Apr; 112(2):175-187. PubMed ID: 33198444
    [Abstract] [Full Text] [Related]

  • 13. Detection of WA B cells in hepatitis C virus infection: a potential prognostic marker for cryoglobulinemic vasculitis and B cell malignancies.
    Knight GB, Gao L, Gragnani L, Elfahal MM, De Rosa FG, Gordon FD, Agnello V.
    Arthritis Rheum; 2010 Jul; 62(7):2152-9. PubMed ID: 20506150
    [Abstract] [Full Text] [Related]

  • 14. Persistence of mixed cryoglobulinemia despite cure of hepatitis C with new oral antiviral therapy including direct-acting antiviral sofosbuvir: A case series.
    Cornella SL, Stine JG, Kelly V, Caldwell SH, Shah NL.
    Postgrad Med; 2015 May; 127(4):413-7. PubMed ID: 25746436
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mixed cryoglobulinemia as a model of systemic vasculitis.
    Dammacco F, Sansonno D.
    Clin Rev Allergy Immunol; 1997 May; 15(1):97-119. PubMed ID: 9209804
    [Abstract] [Full Text] [Related]

  • 17. Cryoglobulinemic disease.
    Retamozo S, Brito-Zerón P, Bosch X, Stone JH, Ramos-Casals M.
    Oncology (Williston Park); 2013 Nov; 27(11):1098-1105, 1110-6. PubMed ID: 24575538
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Understanding the Cryoglobulinemias.
    Fuentes A, Mardones C, Burgos PI.
    Curr Rheumatol Rep; 2019 Nov 19; 21(11):60. PubMed ID: 31741077
    [Abstract] [Full Text] [Related]

  • 20. Are direct-acting antivirals safe and effective in hepatitis C virus-cryoglobulinemia? virological, immunological, and clinical data from a real-life experience.
    Passerini M, Schiavini M, Magni CF, Landonio S, Niero F, Passerini S, Croci AL, Bolis M, Scalzi V, Gubertini G, Ricci ED, Galli M, Rizzardini G.
    Eur J Gastroenterol Hepatol; 2018 Oct 19; 30(10):1208-1215. PubMed ID: 30138160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.